ADMA Biologics logo
ADMA Biologics ADMA
$ 19.39 0.1%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

ADMA Biologics Financial Ratios 2011-2024 | ADMA

Annual Financial Ratios ADMA Biologics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-42.8 -9.2 -2.7 -2.5 -4.6 -2.2 -2.0 -3.2 -3.5 - -3.6 - -

P/S

4.7 3.9 2.4 4.5 7.6 8.4 3.8 5.8 8.8 - 18.2 - -

EPS

-0.1 -0.3 -0.5 -0.9 -0.9 -1.4 -1.9 -1.6 -1.7 -1.8 -2.4 -1.8 -16.7

EV (Enterprise Value)

1.35 B 717 M 281 M 255 M 296 M 189 M 112 M 80.3 M 75.3 M 571 M 40.1 M -6.4 M -78 K

EBITDA per Share

0.13 -0.17 -0.38 -0.745 -0.747 -1.32 -1.63 -1.39 -1.44 - -2.27 - -

EV/EBITDA

-4.2 -3.6 -6.9 -2.8 -2.3 -4.3 -4.5 - -2.3 - -

PEG

0.66 0.28 0.15 -2.25 -0.12 -0.09 0.11 -0.46 -0.79 - 0.07 - -

P/B

8.9 4.0 1.4 2.2 8.5 7.2 2.2 -13.9 76.5 36.0 2.6 - -

P/CF

137.4 -10.2 -1.8 -1.7 -2.8 -2.2 -2.2 -3.4 -4.1 - -5.0 - -

ROE %

-20.89 -43.37 -50.75 -85.83 -184.32 -332.53 -108.49 437.83 -2188.85 - -71.97 - -

ROA %

-8.58 -18.91 -25.94 -36.47 -37.99 -73.97 -40.51 -82.39 -75.78 - -48.55 - -

ROCE %

16.00 -25.90 -41.35 -34.58 -36.64 -76.07 -39.02 -139.06 -79.57 - -53.11 - -

Current Ratio

1.7 1.8 2.0 7.7 6.1 4.6 6.7 1.9 5.0 7.2 8.5 - -

DSO

30.3 52.2 94.3 114.4 43.2 29.9 62.2 34.9 47.0 - - - -

DIO

362.5 442.4 471.9 485.6 490.3 161.0 158.0 288.1 291.7 - 301.1 - -

DPO

31.1 39.4 53.8 65.9 84.8 51.0 74.1 147.2 176.8 - 488.8 - -

Operating Cycle

392.8 494.6 566.2 600.0 533.4 191.0 220.3 322.9 338.7 - 301.1 - -

Cash Conversion Cycle

361.6 455.2 512.4 534.1 448.7 139.9 146.2 175.8 162.0 - -187.7 - -

All numbers in USD currency

Quarterly Financial Ratios ADMA Biologics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.14 0.08 - 0.01 -0.03 -0.03 - -0.08 -0.07 -0.13 - -0.13 -0.15 -0.16 - -0.19 -0.23 -0.26 - -0.19 -0.25 -0.28 -0.39 -0.33 -0.35 -0.39 - -0.59 -0.55 -0.51 - -0.34 -0.5 -0.43 - -0.48 -0.44 -0.37 - -0.36 -0.43 -0.64 - -0.46 -0.83 -0.55 - -0.55 -0.2 -0.18 - -2.79 - -4.5

EBITDA per Share

0.18 0.1 - 0.05 0.01 - - -0.04 -0.04 -0.07 - -0.1 -0.11 -0.12 - -0.15 -0.19 -0.22 - -0.14 -0.2 -0.27 -0.35 -0.28 -0.29 -0.35 - -0.53 -0.49 -0.45 - -0.28 -0.44 -0.38 - -0.42 -0.32 -0.31 - -0.32 -0.38 -0.61 - -0.42 -0.81 -0.53 - -0.54 -0.2 -0.35 - -1.75 -5.12 -3.75

ROE %

32.00 10.63 -7.31 -22.15 -38.69 -46.38 -46.58 -63.81 -66.20 -71.11 -50.51 -69.68 -71.62 -77.54 -63.84 -107.51 -132.01 -159.59 -144.00 -235.24 -268.12 -292.28 -332.53 -278.99 -240.13 -187.94 -76.31 20.87 155.73 313.03 335.54 -285.97 -1004.65 -1709.51 -1630.66 -1686.99 -1121.81 -617.76 -220.51 -232.98 -189.11 -145.88 -50.18 -84.62 -106.60 -96.72 -53.59 -55.74 -275.59 -266.28 -669.56 -254.29 -3.50 -409.62

ROA %

15.06 4.69 -3.11 -8.07 -13.76 -16.54 -17.71 -25.13 -27.60 -31.08 -23.34 -31.49 -32.21 -33.81 -27.13 -36.13 -36.98 -36.49 -28.50 -48.80 -56.83 -64.20 -73.97 -67.75 -64.79 -56.57 -28.49 -46.78 -50.99 -68.01 -63.15 -84.66 -87.89 -82.24 -56.45 -68.98 -59.99 -54.91 -48.87 -57.28 -53.16 -53.81 -33.85 -54.72 -67.18 -59.63 -32.46 -32.75 -45.41 -38.12 -88.29 -33.53 -0.46 -54.01

ROCE %

46.49 25.34 4.85 -4.43 -19.44 -27.14 -28.97 -43.02 -47.78 -53.73 -41.49 -57.13 -58.72 -64.16 -54.05 -88.60 -107.51 -131.40 -128.27 -211.97 -247.17 -271.75 -304.94 -257.02 -223.03 -176.00 -71.32 12.51 132.12 276.14 300.32 -267.81 -919.77 -1471.31 -1386.54 -1437.11 -919.54 -550.90 -204.86 -216.60 -177.76 -140.51 -48.78 -83.26 -106.00 -96.35 -60.16 -259.26 -423.88 -967.69 -1166.70 -199.10 -556.61 -410.98

Current Ratio

2.0 1.8 1.7 1.8 1.8 1.8 1.8 1.5 1.6 1.7 2.0 1.8 1.9 1.9 1.7 1.7 1.7 1.7 1.3 1.3 1.4 1.3 1.3 1.3 1.3 1.3 1.6 1.6 1.6 1.6 0.8 0.8 0.8 0.8 1.0 1.0 1.0 1.0 1.3 1.3 1.3 1.3 3.1 3.1 3.1 3.1 2.5 2.5 2.5 2.5 1.1 1.1 1.1 1.1

DSO

33.9 42.9 - 46.1 48.0 33.7 - 44.2 59.9 85.0 - 96.9 99.5 81.3 - 117.5 155.1 74.7 - 43.8 48.3 62.9 31.3 30.0 27.3 59.5 - 74.9 104.2 85.0 - 31.6 40.9 41.7 - 45.5 64.4 39.7 - 25.6 23.4 11.2 - - 20.0 21.0 - 9.9 15.5 405.6 - - - -

DIO

328.0 374.1 - 347.8 342.2 369.6 - 448.5 497.9 473.2 - 480.7 469.6 451.1 - 627.6 551.3 364.9 - 611.7 461.5 347.7 152.5 185.4 176.1 116.4 - 102.1 265.9 4414.8 - 1401.7 1197.0 - - - - - - - - - - - - - - - - - - - - -

DPO

28.8 35.0 - 24.6 26.3 29.6 - 53.1 44.5 47.6 - 52.7 44.4 59.6 - 85.2 74.9 54.9 - 105.8 79.8 73.1 48.3 58.8 55.8 44.0 - 47.9 124.7 2122.7 - 716.1 611.5 - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

361.9 417.0 - 393.9 390.2 403.3 - 492.7 557.8 558.2 - 577.6 569.2 532.4 - 745.1 706.4 439.6 - 655.5 509.8 410.6 183.8 215.4 203.4 176.0 - 176.9 370.0 4499.9 - 1433.3 1237.9 41.7 - 45.5 64.4 39.7 - 25.6 23.4 11.2 - - 20.0 21.0 - 9.9 15.5 405.6 - - - -

Cash Conversion Cycle

333.1 382.0 - 369.4 363.9 373.7 - 439.6 513.3 510.6 - 524.9 524.8 472.8 - 659.9 631.5 384.8 - 549.8 430.0 337.5 135.5 156.7 147.6 131.9 - 129.1 245.4 2377.1 - 717.2 626.4 41.7 - 45.5 64.4 39.7 - 25.6 23.4 11.2 - - 20.0 21.0 - 9.9 15.5 405.6 - - - -

All numbers in USD currency